Can metaplastic carcinoma be cured?
Metaplastic breast cancer (MpBC) is a rare type of fast-growing breast cancer that can spread anywhere in the body. Doctors often detect it in the later stages, so it is not curable, but treatment can help people manage the disease.
What is the survival rate for spindle cell carcinoma?
The median overall survival time was 8.89 months. The 1-year overall survival rate was 36.7% and the 3-year overall survival rate was 27.5%. In the early stage group, the 1-year and 3-year survival rates were both 100%.
What is spindle cell carcinoma?
Spindle cell carcinoma represents a rare variant of squamous cell carcinoma, characterized by spindled tumor cells that simulate a sarcoma but are epithelial in nature. The tumor can arise anywhere within the upper aerodigestive tract, with a predilection for the larynx and oral cavity.
How is metaplastic carcinoma treated?
Metaplastic Breast Cancer Staging and Treatment Local therapy is aimed at preventing the cancer from coming back in the breast. Local therapy includes surgery (lumpectomy or mastectomy), and may include radiation. Systemic therapy is used to prevent the disease from coming back or spreading to another part of the body.
What causes Metaplastic carcinoma?
According to the National Institutes of Health (NIH), there are no known inherited genetic predisposing risk factors for metaplastic breast cancer. The cause for this type of cancer is not known. Known risk factors for any breast cancer include: age — most breast cancers are diagnosed after age 50.
Is spindle cell carcinoma serious?
Summary. Spindle cell carcinoma (SCC) is a rare pulmonary malignancy, accounting for only 0.2%–0.3% of all lung cancers. Therefore, the prognosis and treatment of pulmonary SCC is unclear. There are only 13 reported cases in literature, only three of which had a survival of more than 11 months.